Target Audience
This activity is intended for pulmonologists, rheumatologists, and other clinicians who may encounter patients with ILDs and/or connective tissue diseases.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Diagnose interstitial lung diseases in a timely manner through optimal use of diagnostic criteria and radiologic findings
- Chart disease course during the management of ILDs
- Optimize treatment response in the management of ILDs with appropriate assessment and follow-up
- Develop evidence-based, individualized treatment plans for ILD management
Faculty
Imre Noth, MD
Professor of Medicine
Chief, Division of Pulmonary and Critical Care
University of Virginia
Charlottesville, Virginia
David Lederer, MD
Associate Professor of Medicine and Epidemiology
Director, Advanced Lung Disease Program
Co-director, Interstitial Lung Disease Program
Director, Pulmonary & Intensive Care Translational Outcomes Research
Columbia University
New York, New York
Accreditation
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of
1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The
Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.
This program is designated for up to
1.5 contact hours. Program ID# 56300.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.5
contact hours. To receive credit for education contact hours outside of the state of California,
please check with your state board of registered nursing for reciprocity.
Certificates will be available online at the Web address noted on the evaluation. For Pharmacists
and Pharmacy Technologists- Transcript information will be available at www.mycpemonitor.net
within 4 weeks.
Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:
Imre Noth, MD
- Research Support: Boehringer Ingelheim - clinical area: Interstitial lung disease, Genentech - clinical area: Interstitial lung disease
- Consultant: Veracyte - clinical area: Interstitial lung disease, Roche - clinical area: Interstitial lung disease, Galapagos - clinical area: Interstitial lung disease
David Lederer, MD
- Research Support: Covidien - clinical area: Interstitial lung disease, Boehringer Ingelheim - clinical area: Interstitial lung disease
- Consultant: Veracyte - clinical area: Interstitial lung disease, Roche - clinical area: Interstitial lung disease, Galapagos - clinical area: Interstitial lung disease
The faculty for this activity has disclosed that there will be
no
discussion about the use of products for non-FDA approved applications.
Additional Content Planners
Gregory Scott, PharmD, RPh (medical writer)
Gene Cullen, MD (peer reviewer)
Heather Jimenez (nurse reviewer)
Annenberg Center for Health Sciences
Charles Willis, Director, Continuing Education, consults for Pfizer, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
This activity is supported by an independent educational grant from Genentech.
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications in your practice, and completing the assessment component.
The estimated time to complete the activity is
1.5 hours.
This activity was originally released on
November 30, 2018 and is eligible for credit through
November 29, 2019.
Our Policy on Privacy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/
Contact Information
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
ce@annenberg.net
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday